2.Wormsbecker, AE, et al. (2015) Twenty years of medically-attended pediatric varicella and Herpes Zoster in Ontario, Canada: a population-based study. PLoS ONE 10(7), e0129483.
3.Humes, EA, et al. (2015) Trends in hospitalizations with primary varicella and herpes zoster during the prevaricella and initial postvaricella and herpes zoster vaccine eras, Connecticut, 1994–2012. Open Forum Infectious Diseases 2(1), ofv001.
4.Elbaz, M, et al. (2015) Immunisation led to a major reduction in paediatric patients hospitalised because of the varicella infection in Israel. Acta Paediatrica 105(4), e161–e166.
5.Bechini, A, et al. (2015) Impact of universal vaccination against varicella in Italy. Human Vaccines & Immunotherapeutics 11(1), 63–71.
6.Brisson, M, et al. (2000) Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiology and Infection 125(3), 651–669.
8.Tse, WKM and Mok, T. (2002) Survey on immunisation coverage among children aged two to five: Department of Health, Hong Kong SAR Government; 2002. Public Health & Epidemiology Bulletin 11, 13–18.
9.Tse, WKM and Yeung, SWT (2004) Immunisation coverage among children aged two to five: an update: Department of Health, Hong Kong SAR Government. Public Health & Epidemiology Bulletin 13, 7–15.
10.Wu, T, Chan, SK, Kung, KH, Lau, W, Choi, T (2007) Immunisation coverage among children aged two to five: findings of the 2006 survey: Department of Health, Hong Kong SAR Government. Public Health & Epidemiology Bulletin 16, 57–68.
11.Chan, D, Chan, SK, Wong, SCK, Chan, A (2010) Immunisation coverage among children aged two to five: findings of the 2009 immunisation survey. Public Health & Epidemiology Bulletin 19, 53–63.
12.Centre for Health Protection, Department of Health, Hong Kong SAR Government (2014) Immunisation coverage for children aged two to five: findings of the 2012 immunisation survey. Communicable Diseases Watch 11(13), 55–57.
13.Centre for Health Protection, Department of Health, Hong Kong SAR Government (2017) Immunisation coverage for children aged two to five: findings of the 2015 immunisation survey. Communicable Diseases Watch 14(6), 23–26.
14.Wong, JMS and Rao, N (2015) The evolution of early childhood education policy in Hong Kong. International Journal of Child Care and Education Policy 9(1), 3.
17.Lee, KH, Gillette, S (2010) Introducing Pay-for-Performance within Hong Kong's Public Hospitals. BMC Health Services Research 10(Suppl. 2), A17.
20.Hens, N, et al. (2010) Seventy-five years of estimating the force of infection from current status data. Epidemiology and Infection 138(6), 802–812.
21.Nardone, A, et al. (2007) The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 25(45), 7866–7872.
22.Sauerbrei, A, et al. (2012) Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test. Clinical and Vaccine Immunology 19(8), 1261–1268.
23.Vynnycky, E, White, GR, Fine, PE (2010) Chapter 18.104.22.168. The basic reproduction number. In Pinteau, G, Wilson, N, Butterworth, A and Wright, J (eds.). An Introduction to Infectious Disease Modelling. Oxford: Oxford University Press, pp. 115–116.
26.Gidding, HF, et al. (2003) The seroepidemiology and transmission dynamics of varicella in Australia. Epidemiology and Infection 131(3), 1085–1089.
27.The United Nations (1997) 1995 Demographic Yearbook.
28.Kwok, KO, et al. (2014) Social contacts and the locations in which they occur as risk factors for influenza infection. Proceedings of the Royal Society B 281(1789), 20140709.
31.Arvin, AM (1999) Chickenpox (varicella). Contributions to Microbiology 3, 96–110.
32.Wutzler, P and Sauerbrei, A (1999) Infections during pregnancy. Contributions to Microbiology 3, 141–149.
33.Ogunjimi, B, Van Damme, P and Beutels, P (2013) Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review. PLoS ONE 8(6), e66485.
37.Ciofi Degli Atti, ML, et al. (2002) Assessment of varicella underreporting in Italy. Epidemiology and Infection 128(3), 479–484.
38.Goldman, GS (2003) Using capture-recapture methods to assess varicella incidence in a community under active surveillance. Vaccine 21(27–30), 4250–4255.
39.Lin, F and Hadler, JL (2000) Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era. Journal of Infectious Diseases 181(6), 1897–1905.
40.Kelly, H, et al. (2002) A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine 20(25–26), 3130–3136.
42.Brisson, M, et al. (2002) Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 20(19–20), 2500–2507.
43.Krause, PR and Klinman, DM (2000) Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children. Nature Medicine 6(4), 451–454.